Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle

被引:122
作者
Hartong, Dyonne T. [1 ]
Dange, Mayura [2 ]
McGee, Terri L. [1 ]
Berson, Eliot L. [3 ]
Dryja, Thaddeus P. [1 ]
Colman, Roberta F. [2 ]
机构
[1] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Mol Genet Inst, Boston, MA 02114 USA
[2] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA
[3] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA
关键词
D O I
10.1038/ng.223
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Here we describe two families with retinitis pigmentosa, a hereditary neurodegeneration of rod and cone photoreceptors in the retina. Affected family members were homozygous for loss-of-function mutations in IDH3B, encoding the beta-subunit of NAD-specific isocitrate dehydrogenase (NAD-IDH, or IDH3), which is believed to catalyze the oxidation of isocitrate to a-ketoglutarate in the citric acid cycle. Cells from affected individuals had a substantial reduction of NAD-IDH activity, with about a 300-fold increase in the Km for NAD. NADP-specific isocitrate dehydrogenase (NADP-IDH, or IDH2), an enzyme that catalyzes the same reaction, was normal in affected individuals, and they had no health problems associated with the enzyme deficiency except for retinitis pigmentosa. These findings support the hypothesis that mitochondrial NADP-IDH, rather than NAD-IDH, serves as the main catalyst for this reaction in the citric acid cycle outside the retina, and that the retina has a particular requirement for NAD-IDH.
引用
收藏
页码:1230 / 1234
页数:5
相关论文
共 23 条
  • [1] Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa
    Chakarova, CF
    Hims, MM
    Bolz, H
    Abu-Safieh, L
    Patel, RJ
    Papaioannou, MG
    Inglehearn, CF
    Keen, TJ
    Willis, C
    Moore, AT
    Rosenberg, T
    Webster, AR
    Bird, AC
    Gal, A
    Hunt, D
    Vithana, EN
    Bhattacharya, SS
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (01) : 87 - 92
  • [2] DIPHOSPHOPYRIDINE NUCLEOTIDE DEPENDENT ISOCITRATE DEHYDROGENASE FROM PIG HEART - CHARACTERIZATION OF ACTIVE SUBSTRATE AND MODES OF REGULATION
    COHEN, PF
    COLMAN, RF
    [J]. BIOCHEMISTRY, 1972, 11 (08) : 1501 - +
  • [3] Daiger Stephen P, 2004, Novartis Found Symp, V255, P17
  • [4] DOLPHIN D, 1987, PYRIDINE NUCLEOTID B, V606
  • [5] Using microarrays to facilitate positional cloning: Identification of tomosyn as an inhibitor of neurosecretion
    Dybbs, M
    Ngai, J
    Kaplan, JM
    [J]. PLOS GENETICS, 2005, 1 (01): : 6 - 16
  • [6] GARRETT RH, 2004, BIOCHEMISTRY, V618
  • [7] Regulation of the human inosine monophosphate dehydrogenase type I gene - Utilization of alternative promoters
    Gu, JJ
    Spychala, J
    Mitchell, BS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (07) : 4458 - 4466
  • [8] Retinitis pigmentosa
    Hartong, Dyonne T.
    Berson, Eliot L.
    Dryja, Thaddeus P.
    [J]. LANCET, 2006, 368 (9549) : 1795 - 1809
  • [9] HOEK JB, 1988, BIOCHEM J, V254, P1
  • [10] Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer
    Huusko, P
    Ponciano-Jackson, D
    Wolf, M
    Kiefer, JA
    Azorsa, DO
    Tuzmen, S
    Weaver, D
    Robbins, C
    Moses, T
    Allinen, M
    Hautaniemi, S
    Chen, YD
    Elkahloun, A
    Basik, M
    Bova, GS
    Bubendorf, L
    Lugli, A
    Sauter, G
    Schleutker, J
    Ozcelik, H
    Elowe, S
    Pawson, T
    Trent, JM
    Carpten, JD
    Kallioniemi, OP
    Mousses, S
    [J]. NATURE GENETICS, 2004, 36 (09) : 979 - 983